Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Caribou Biosciences stock

Learn how to easily invest in Caribou Biosciences stock.

Caribou Biosciences is a biotechnology business based in the US. Caribou Biosciences shares (CRBU) are listed on the NASDAQ and all prices are listed in US Dollars.

How to buy Caribou Biosciences stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – CRBU. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award


  • Trade stocks and ETFs for $0 and no annual fee
  • Minimum deposit of $10 required
  • FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100

Promoted for easy user experience


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Caribou Biosciences stock price (NASDAQ: CRBU)

Use our graph to track the performance of CRBU stocks over time.

Caribou Biosciences shares at a glance

Information last updated 2023-01-26.
Latest market close$7.43
52-week range$4.89 - $13.19
50-day moving average $7.80
200-day moving average $8.48
Wall St. target price$29.14
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.64

Buy Caribou Biosciences stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
Stocks, Options, ETFs, Cryptocurrency
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Caribou Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Caribou Biosciences price performance over time

Historical closes compared with the close of $7.43 from 2023-02-01

1 week (2023-01-26) 7.06%
1 month (2022-12-30) 18.31%
3 months (2022-11-02) -21.38%
6 months (2022-08-02) -7.24%
1 year (2022-02-02) -29.04%
2 years (2021-01-29) N/A
3 years (2020-01-29) N/A
5 years (2018-01-29) N/A

Caribou Biosciences financials

Revenue TTM $12.7 million
Gross profit TTM $-42,657,000
Return on assets TTM -13.97%
Return on equity TTM -24.96%
Profit margin 0%
Book value $5.31
Market capitalisation $423.4 million

TTM: trailing 12 months

Caribou Biosciences share dividends

We're not expecting Caribou Biosciences to pay a dividend over the next 12 months.

Caribou Biosciences overview

Caribou Biosciences, Inc. , a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy for the treatment of relapsed or refractory multiple myeloma. The company also develops CB-012, an allogeneic anti-CD371 CAR-T cell therapy for the treatment of relapsed or refractory acute myeloid leukemia; and CB-020, an allogeneic CAR-NK cell therapy for the treatment of solid tumors. It has collaboration with AbbVie Manufacturing Management Unlimited Company to develop CAR-T cell therapies. The company was incorporated in 2011 and is headquartered in Berkeley, California. .

Frequently asked questions

What percentage of Caribou Biosciences is owned by insiders or institutions?
Currently 10.792% of Caribou Biosciences shares are held by insiders and 72.346% by institutions.
When does the fiscal year end for Caribou Biosciences?
Caribou Biosciences's fiscal year ends in December.
Where is Caribou Biosciences based?
Caribou Biosciences's address is: 2929 7th Street, Berkeley, CA, United States, 94710
What is Caribou Biosciences's ISIN number?
Caribou Biosciences's international securities identification number is: US1420381089

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site